Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Nazzal

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Viral Hepatitis|June 12, 2018
Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real-world experience studyR Flisiak, E Janczewska, M Łucejko, et al.
Aging|November 22, 2024
The effects of young and aged, male and female megakaryocyte conditioned media on angiogenic properties of endothelial cellsMurad K Nazzal, Hanisha L Battina, Nikhil P Tewari, et al.
Bone|July 27, 2025
Evaluating the usage of human placental tissue-derived xenograft in a surgically induced murine fracture modelUpasana Ganguly, Tyler J Margetts, Will Varner Anou, et al.
Bone|February 13, 2021
The effects of high fat diet, bone healing, and BMP-2 treatment on endothelial cell growth and functionFazal Ur Rehman Bhatti, Ushashi C Dadwal, Conner R Valuch, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 23, 2021
The effects of bone morphogenetic protein 2 and thrombopoietin treatment on angiogenic properties of endothelial cells derived from the lung and bone marrow of young and aged, male and female miceUshashi C Dadwal, Fazal Ur Rehman Bhatti, Olatundun D Awosanya, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2016
Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER studyR Flisiak, E Janczewska, M Wawrzynowicz-Syczewska, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Viral Hepatitis|June 12, 2018
Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real-world experience studyR Flisiak, E Janczewska, M Łucejko, et al.
Aging|November 22, 2024
The effects of young and aged, male and female megakaryocyte conditioned media on angiogenic properties of endothelial cellsMurad K Nazzal, Hanisha L Battina, Nikhil P Tewari, et al.
Bone|July 27, 2025
Evaluating the usage of human placental tissue-derived xenograft in a surgically induced murine fracture modelUpasana Ganguly, Tyler J Margetts, Will Varner Anou, et al.
Bone|February 13, 2021
The effects of high fat diet, bone healing, and BMP-2 treatment on endothelial cell growth and functionFazal Ur Rehman Bhatti, Ushashi C Dadwal, Conner R Valuch, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 23, 2021
The effects of bone morphogenetic protein 2 and thrombopoietin treatment on angiogenic properties of endothelial cells derived from the lung and bone marrow of young and aged, male and female miceUshashi C Dadwal, Fazal Ur Rehman Bhatti, Olatundun D Awosanya, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2016
Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER studyR Flisiak, E Janczewska, M Wawrzynowicz-Syczewska, et al.
Pageof 2